Based on previous diagnostic recommendations, we classified a Ki-67 positive percent of >20% as cSCC and that of ≤20% as KA [7, 8], along with our summary of the C-Myc expression pattern in these patients. This evidence concerns the gene MKI67 and skin squamous cell carcinoma.